164 related articles for article (PubMed ID: 19382747)
1. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
Shaffer JM; Hellwig S; Smithgall TE
Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
[TBL] [Abstract][Full Text] [Related]
2. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
Cheng H; Rogers JA; Dunham NA; Smithgall TE
Mol Cell Biol; 1999 Dec; 19(12):8335-43. PubMed ID: 10567558
[TBL] [Abstract][Full Text] [Related]
3. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.
Cheng HY; Schiavone AP; Smithgall TE
Mol Cell Biol; 2001 Sep; 21(18):6170-80. PubMed ID: 11509660
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.
Read RD; Lionberger JM; Smithgall TE
J Biol Chem; 1997 Jul; 272(29):18498-503. PubMed ID: 9218495
[TBL] [Abstract][Full Text] [Related]
5. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.
Gnemmi I; Scotti C; Cappelletti D; Canonico PL; Condorelli F; Rosano C
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):18-20. PubMed ID: 17183165
[TBL] [Abstract][Full Text] [Related]
7. Structure and regulation of the c-Fes protein-tyrosine kinase.
Hellwig S; Smithgall TE
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3146-55. PubMed ID: 21622225
[TBL] [Abstract][Full Text] [Related]
8. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ; Stevenson H; Smithgall TE
J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
[TBL] [Abstract][Full Text] [Related]
9. The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly.
Laurent CE; Delfino FJ; Cheng HY; Smithgall TE
Mol Cell Biol; 2004 Nov; 24(21):9351-8. PubMed ID: 15485904
[TBL] [Abstract][Full Text] [Related]
10. The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.
Delfino FJ; Shaffer JM; Smithgall TE
Biochem J; 2006 Oct; 399(1):141-50. PubMed ID: 16792528
[TBL] [Abstract][Full Text] [Related]
11. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
12. Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells.
McPherson VA; Everingham S; Karisch R; Smith JA; Udell CM; Zheng J; Jia Z; Craig AW
Mol Cell Biol; 2009 Jan; 29(2):389-401. PubMed ID: 19001085
[TBL] [Abstract][Full Text] [Related]
13. The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.
Lionberger JM; Smithgall TE
Cancer Res; 2000 Feb; 60(4):1097-103. PubMed ID: 10706130
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
15. Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.
Tagliafico E; Siena M; Zanocco-Marani T; Manfredini R; Tenedini E; Montanari M; Grande A; Ferrari S
Oncogene; 2003 Mar; 22(11):1712-23. PubMed ID: 12642874
[TBL] [Abstract][Full Text] [Related]
16. The c-Fes family of protein-tyrosine kinases.
Smithgall TE; Rogers JA; Peters KL; Li J; Briggs SD; Lionberger JM; Cheng H; Shibata A; Scholtz B; Schreiner S; Dunham N
Crit Rev Oncog; 1998; 9(1):43-62. PubMed ID: 9754447
[TBL] [Abstract][Full Text] [Related]
17. Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.
Filippakopoulos P; Kofler M; Hantschel O; Gish GD; Grebien F; Salah E; Neudecker P; Kay LE; Turk BE; Superti-Furga G; Pawson T; Knapp S
Cell; 2008 Sep; 134(5):793-803. PubMed ID: 18775312
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
Shaffer JM; Smithgall TE
Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
[TBL] [Abstract][Full Text] [Related]
19. FES/FER kinase signaling in hematopoietic cells and leukemias.
Craig AW
Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.
Kanda S; Miyata Y; Kanetake H; Smithgall TE
Int J Oncol; 2009 Jan; 34(1):89-96. PubMed ID: 19082481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
